Rislenemdaz hydrochloride

• Description :

  Rislenemdaz (MK 0657; CERC 301) is a potent, orally bioavailable, brain‐penetrant, NR2B-selective NMDA receptor (GluN2B) antagonist with Ki and IC 50 of 8.1 nM and 3.6 nM respectively.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  394.875

• Molecular Formula :

  C19H24ClFN4O2

• Notes :

  Research use only, not for human use.

• Receptor :

  IGluR

• CAS Number :

  808733-06-4